Differential Expression of Long Noncoding RNAs Reveals a Potential Biomarker for Intractable Pemphigus

Figure 3

Associations between the expression level of ENST00000585297 and clinical features. (a) Expression of ENST00000585297 was upregulated in pemphigus patients whose symptoms could not be managed within four weeks () compared with other patients whose symptoms could be managed in four weeks or less () (). (b) ENST00000585297 expression in pemphigus patients () was positively correlated with dosage of prednisone treatment (, ). (c) The expression of ENST00000585297 of the recurrent pemphigus patients were higher than those in the new-onset patients (). (d–f) No significant correlation was observed between ENST00000585297 and PDAI or antibody titers in pemphigus patients (, ). (g–i) No significant difference of PDAI, Dsg1, or Dsg3 was seen between the two groups (). (, , and ; ns: ).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)